SEC Class Action Lawsuits Filed Against Biotech Companies

Multiple class action lawsuits were filed against several biotech companies, including ADMA Biologics, First Solar, and Zoetis Inc., alleging securities fraud and false statements. Investors who purchased shares during specified periods may be eligible for compensation. Lead plaintiff deadlines range from July 27 to August 24, 2026.

Law firms have filed class action lawsuits against several biotech companies for alleged securities fraud and false statements [doc1, doc12]. ADMA Biologics is accused of making false statements and concealing practices . Zoetis Inc. is facing allegations of providing misleading information about its Companion Animal segment, including the weakening adoption of Librela, market share losses for Simparica Trio, and declining sales of Apoquel and Cytopoint [doc3, doc12].

Another lawsuit was filed against First Solar, Inc., alleging that company executives provided false statements and failed to disclose material facts about the company's ability to manage U.S. tariff policy impacts .

The lawsuits also mention investors with a lead plaintiff deadline for each case, ranging from July 27 to August 24, 2026. These developments indicate ongoing regulatory scrutiny and potential financial repercussions for companies involved.

Investors in ADMA Biologics, First Solar, Roblox Corporation, and Zoetis Inc. are affected. For those planning to join the lawsuits, there is no guarantee of recoverable losses.